Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xenon inhalational anesthesia vs total intravenous anesthesia in ASA III patients with stable coronary heart disease
2007-001979-10Phase 3Completed
- Sponsor
- Air Liquide
- Start
- Mar 2008
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of xenon in coronary arteriosclerosis (3 arms), sponsored by Air Liquide. Primary endpoint: Propofol consumption adjusted for body surface area and anesthesia duration. Started Mar 2008; status: completed.
02
Drugs
xenon
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2007-001979-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001979-10.